Similarly, in the microarray cohort, Cluster3 was correlated with favorable survival and recurrence status (P = 0.009, P = 0.045), longer survival and recurrence time (P < 0.001, P < 0.001), lower serum AFP level (P < 0.001), smaller tumor size (P = 0.01), and early TNM and BCLC staging (P = 0.005, P = 0.041). The gene discussed is AFP; the disease is neoplasm.